Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | African trypanosomiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
2 | African trypanosomiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
3 | African trypanosomiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
4 | African trypanosomiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
5 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
6 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
7 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
8 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
9 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
10 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
11 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
12 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
13 | Alzheimer disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
14 | Alzheimer disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
15 | Alzheimer disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
16 | Alzheimer disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
17 | Amoebiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
18 | Amoebiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
19 | Amoebiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
20 | Amoebiasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
21 | Antifolate resistance 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
22 | Antifolate resistance 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
23 | Antifolate resistance 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
24 | Antifolate resistance 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
25 | C-type lectin receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
26 | C-type lectin receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
27 | C-type lectin receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
28 | C-type lectin receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
29 | Chagas disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
30 | Chagas disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
31 | Chagas disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
32 | Chagas disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
33 | Coronavirus disease - COVID-19 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
34 | Coronavirus disease - COVID-19 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
35 | Coronavirus disease - COVID-19 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
36 | Coronavirus disease - COVID-19 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
37 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
38 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
39 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
40 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
41 | Cytosolic DNA-sensing pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
42 | Cytosolic DNA-sensing pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
43 | Cytosolic DNA-sensing pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
44 | Cytosolic DNA-sensing pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
45 | Fluid shear stress and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
46 | Fluid shear stress and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
47 | Fluid shear stress and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
48 | Fluid shear stress and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
49 | Graft-versus-host disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
50 | Graft-versus-host disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
51 | Graft-versus-host disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
52 | Graft-versus-host disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
53 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
54 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
55 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
56 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
57 | Herpes simplex virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
58 | Herpes simplex virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
59 | Herpes simplex virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
60 | Herpes simplex virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
61 | Human cytomegalovirus infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
62 | Human cytomegalovirus infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
63 | Human cytomegalovirus infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
64 | Human cytomegalovirus infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
65 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
66 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
67 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
68 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
69 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
70 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
71 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
72 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
73 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
74 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
75 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
76 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
77 | Influenza A 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
78 | Influenza A 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
79 | Influenza A 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
80 | Influenza A 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
81 | Legionellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
82 | Legionellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
83 | Legionellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
84 | Legionellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
85 | Leishmaniasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
86 | Leishmaniasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
87 | Leishmaniasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
88 | Leishmaniasis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
89 | Lipid and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
90 | Lipid and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
91 | Lipid and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
92 | Lipid and atherosclerosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
93 | Malaria 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
94 | Malaria 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
95 | Malaria 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
96 | Malaria 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
97 | MAPK signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
98 | MAPK signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
99 | MAPK signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
100 | MAPK signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
101 | Measles 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
102 | Measles 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
103 | Measles 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
104 | Measles 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
105 | Necroptosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
106 | Necroptosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
107 | Necroptosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
108 | Necroptosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
109 | NF-kappa B signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
110 | NF-kappa B signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
111 | NF-kappa B signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
112 | NF-kappa B signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
113 | NOD-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
114 | NOD-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
115 | NOD-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
116 | NOD-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
117 | Non-alcoholic fatty liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
118 | Non-alcoholic fatty liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
119 | Non-alcoholic fatty liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
120 | Non-alcoholic fatty liver disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
121 | Osteoclast differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
122 | Osteoclast differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
123 | Osteoclast differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
124 | Osteoclast differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
125 | Pathogenic Escherichia coli infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
126 | Pathogenic Escherichia coli infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
127 | Pathogenic Escherichia coli infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
128 | Pathogenic Escherichia coli infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
129 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
130 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
131 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
132 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
133 | Pertussis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
134 | Pertussis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
135 | Pertussis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
136 | Pertussis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
137 | Prion disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
138 | Prion disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
139 | Prion disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
140 | Prion disease 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
141 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
142 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
143 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
144 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
145 | Salmonella infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
146 | Salmonella infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
147 | Salmonella infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
148 | Salmonella infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
149 | Shigellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
150 | Shigellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
151 | Shigellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
152 | Shigellosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
153 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
154 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
155 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
156 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
157 | TNF signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
158 | TNF signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
159 | TNF signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
160 | TNF signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
161 | Toll-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
162 | Toll-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
163 | Toll-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
164 | Toll-like receptor signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
165 | Tuberculosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
166 | Tuberculosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
167 | Tuberculosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
168 | Tuberculosis 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
169 | Type I diabetes mellitus 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
170 | Type I diabetes mellitus 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
171 | Type I diabetes mellitus 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
172 | Type I diabetes mellitus 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|
173 | Yersinia infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
174 | Yersinia infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
175 | Yersinia infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
176 | Yersinia infection 💬 1 gene, 4 drugs (DrugBank) and 20 diseases |
IL1B [1] IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 [4] 51, 106, 107, 266 💬
|